WCAP Content


International Congress on Orofacial Pain (ICOP)
Joint meeting of IASP’s Special Interest Group on Orofacial Pain, Asian Academy of Craniomandibular Disorders, and Japanese Society of Orofacial Pain
September 25, 2016 – Yokohama, Japan –Kanagawa Dental Association Hall

 The first day will be presented partly in Japanesse and is entitled "Trends in Orofacial Pain" The second day is titled "Towards an Integrated Classification of OFP"  This classification will additionally attempt to bridge with current headache classifications

Contact: Rafael Benoliel
Email: rafael.benoliel@rutgers.edu
Fee: Free for Registered Congress Attendees

Are Perioperative Opioids Obsolete?
Acute Pain Special Interest Group
September 25, 2016 – Yokohama, Japan – Pacifico Convention Center – Room 313/314

Because of adverse effects and risks, opioid dose reduction has long been a focus of multimodal analgesia for acute pain. Growing appreciation of short-, intermediate- and long-term adverse opioid effects upon individuals and society (e.g., diversion) has spurred progress in identifying and applying nonopioid (including nondrug) analgesics and regional analgesia for moderate-to-severe pain.  Thus, one may question whether perioperative opioid analgesia is routinely needed.  This Satellite Symposium organized by the Acute Pain Special Interest Group surveys the adverse effects of opioids, nondrug alternatives to their use, advances in nonopioid drugs and delivery systems currently available or likely soon to be, and the growing importance of quality control and registries in helping health systems to navigate a likely 'sea change' in standard medical practice that might soon render routine perioperative opioid analgesia obsolete

Contact: Daniel Carr
Registration:onsite in session room
Program schedule
Fee: Free of charge

Brain and New Pain Mechanisms: What We Know So Far and Where We’re Heading
September 25, 2016 – Tokyo, Japan – Sheraton Miyako Hotel Tokyo

This symposium will provide a forum to foster mutual understanding and stimulate engagement between researchers studying human patients and animal models to promote our understanding of the neuroscience behind chronic pain and the development of novel strategies for chronic pain relief. In particular, recent findings provided by two powerful technologies will be presented: non-invasive neuroimaging in patients and advanced neurobiological analyses in various pain models. These have enabled the identification of the physiological, psychological and cognitive influences of chronic pain on the brain pain matrix and have also revealed the dynamics of pharmacological treatments, suggesting future applications of brain activity measurement in clinical settings. Distinguished speakers and researchers from all over the world will present findings and the latest data generated from cutting-edge techniques, which will point us in a promising direction for future science-based pain research.

View Program

Contact: Fusao Kato
Email: fusao@jikei.ac.jp 
Registration: http://toutsu.jp/satellite_symposium  
Fee:Free of charge

Is Joint Pain Unique or Does it Share Common Features with other Musculoskeletal Pain Conditions?
IASP Global Year against Joint Pain Satellite Meeting in Association with SIG on Musculoskeletal Pain
September 25, 2016 - Yokohama, Japan - Pacifico Convention Center - Room 501
Time: 08:45 – 17:15

Joint pain and osteoarthritis in particular is the most frequent musculoskeletal diagnosis in the elderly population. With the expected global growth in the elderly population and concomitant rise in stationary lifestyle choices, the incidence of joint related pain problems is predicted to increase in the coming years. A total of 10-20% of individuals with a regional pain problem (e.g. joint pain) may develop widespread pain suggesting involvement of sensitization. Treating joint pain is, therefore, particularly challenging and is further complicated by the fact that the pathology is decoupled by from the pain. In addition, the underlying pain mechanisms are not fully understood, and those discovered in animals not yet translated into the clinic. This challenges efficient treatment. This symposium is intended audience for basic researchers doing experiments on joint related pain, specialists seeing patients with joint pain problems (e.g. osteoarthritis), rheumatologists, orthopedic surgeons, pain specialists, physiotherapists, specialists and researchers interested in quantitative evaluation and monitoring of pain management and treatment outcome, and specialists involved in quantitative and mechanisms-based pain diagnostics.

View Program

Contact: Lars Arendt-Nielsen
Email: susanne@hst.aau.dk
Registration: Available through the Congress registration website
Fee: IASP members: USD $15
       Non members: USD $30
       Includes Coffee and Beverage Breaks

Neuropathic Pain: What’s New in Mechanisms, Diagnosis, and Neuromodulation Therapy
Neuropathic Pain and Neuromodulation Special Interest Groups
September 25, 2016 - Yokohama, Japan - Pacifico Convention Center -Room 502

This will be a combined Satellite SIG between the Neuropathic Pain SIG and the Neuromodulation SIG. Program objectives are to learn about the newest scientific aspects of neuropathic pain conditions, especially diabetic polyneuropathy, CRPS, new insights in pain transmission at spinal and central level, new technical developments in invasive and non-invasive stimulation techniques. Topics between the two SIGs will be arranged to be common themes between mechanisms medical management and neuromodulation therapies.

View Program

Contact: Volker Tronnier and Mark Wallace
Email: Volker.Tronnier@uksh.de and mswallace@ucsd.edu
Registration: Available through the Congress registration website
Fee: IASP members: USD $180
       Non members: USD $200
       Includes Lunch, Coffee, and Beverage Breaks

Recent Advances in Understanding the Mechanisms and Management of CRPS
Complex Regional Pain Syndrome Special Interest Group
September 25, 2016 – Tokyo, Japan – University of Tokyo

This symposium will provide delegates with an opportunity to hear the most recent evidence and discussion on: the pathophysiological mechanisms of CRPS; what triggers CRPS and potential biomarkers; phenotyping and genotyping to inform future care; bio-psychosocial rehabilitation approaches; and building an international collaborative clinical research community. Both animal and human research will be drawn on to meet the above objectives.

View Program

Contact: Yuji Nakayama
Email: CRPS_SIGS_Symposium2016@kk-kyowa.co.jp 
Registration: https://v3.apollon.nta.co.jp/CRPS_Symposium
Fee: $80 USD

Worldwide Regulatory Pathways for Analgesic Drug Development
Clinical Trials Special Interest Group
September 26, 1PM- Yokohama, Japan- Intercontinental Grand Hotel, Japan SILK Room

This half-day conference will focus on the best regulatory pathways around the world to obtain agency approvals for analgesic drugs. Our presenters will discuss complexities and strategies for analgesic drug development in Europe, the United States and worldwide:

Reading and Interpreting EMA’s Draft Guideline on the Clinical Development of Medicinal Products Intended for the Treatment of Pain: A Primer for Drug Developers
Karoline Buhre, MD -European Medicines Agency (EMA)

Analgesic Regulatory Pathway in the USA: Reading And Interpreting the FDA Draft Analgesic Guidance
Neil Singla, MD- Chief Scientific Officer, Lotus Clinical Research

Complexities of Developing Analgesic Drugs in Multiple Regions of the World
Nathaniel Katz, MD -President, Analgesic Solutions

There is no fee for attendance and all are welcome to attend. To register, please email tim@lotuscr.com with “IASP” in the subject heading. Please include your full name, and company name if applicable. 

Contact: Neil Singla MD, SIG Chair
Email: Neil@LotuCR.com
Registration: Email Tim@LotusCR.com with “IASP” in the subject to register
Fee: Free of charge


Special Dinner Symposium on Placebo Effects

Pain and Placebo Special Interest Group
Expectancy and Placebo Effects – Update on Mechanisms and Their Relevance to Clinical Trial Design, Interpretation and Clinical Practice.
September 27, 2016 – SIG Dinner Event -Yokohama, Japan – Grand Ballroom, Rose Hotel Yokohama

This program aims to bring researchers and clinicians together to provide an update on current research and to prompt discussion and translation to further research and application to clinical care. The program will specifically focus on the psychological and biological aspects of expectancy and placebo effects. Two speakers will provide an update on neurobiological mechanisms of placebo effects with specific focus on the role of expectancy; update on the role of expectancy in the generation and modulation of placebo effects; address the role of expectancies in the design of clinical trials, including the use of placebo controls and the independent use of expectancy as a measure in trials on pain management; discuss the interpretation of clinical trials with large placebo effects or minimal difference between placebo control and index intervention and propose design alternatives; and outline possibilities to ethically augment placebo effects in routine clinical care. This event will feature International Keynote Speakers Fabrizio Benedetti (Italy) and Irving Kirsch (USA).

Contact: Damien Finniss
Email: damien.finniss@sydney.edu.au
Registration: Available through the Congress registration website  
Fee: USD $80
       Includes Banquet Dinner and Beverages

Mechanisms and Management of Neuropathic and Cancer Pain

Chinese Association for the Study of Pain (CASP)
September 28, 2016 - Yokohama, Japan - Pacifico Convention Center -Room 304

The objective is to identify that the canonical and noncanonical atypical pathways of WNT signaling as well as the endocannabinoid(eCB) dependent LTD of spinal glycinergic gate circuitry contributes to development of neuropathic and cancer pain. Neuropathic pain following nerve injury and other severe stress or diseases such as cancer is severe and often intractable, and current drugs and nondrug therapies are still very limited in efficacy. Results from our recent research have opened a new avenue to understanding mechanisms of neuropathic and cancer pain and our findings may result in a targeted clinical approach to treat the neuropathic and cancer pain and similar disorders. Meanwhile, we report epidemiological investigations of cancer pain, our strategy of comprehensive treatment, and summary of decades of experiences in treating severe cancer pain in China. The treatment approaches used include verterbroplasty, sympathetic nerve neurolytic procedure, spinal chemoneurolysis, neuromodulation, intrathecal drug delivery system implantation, as well as Chinese herbal medicine and acupuncture as a supportive intervention for improving life quality of patients.

Contact: Prof. Dr .Xue-Jun Song


Email: xuejunsong@yahoo.com

Fibromyalgia Research Symposium 2016
October 1-2, 2016 - Nagasaki, Japan - St. Priere

Fibromyalgia, an intractable generalized pain syndrome, is known to comprise an approximately 2% population ratio in developed countries. Limited etiology information of fibromyalgia, a representative central pain, delays the reasonable diagnosis and therapy. Current therapy for fibromyalgia predominantly includes the use of existing analgesics and analgesic adjuvants, however, because of their insufficient therapeutic actions and adverse effects, it is still needed to develop and establish effective therapeutic strategies. This satellite symposium will present the advances in establishment of diagnosis, therapeutic markers, and novel therapeutic strategies as well as the development of basic studies on the mechanism of Fibromyalgia in the world.

Contact: Hiroshi Ueda
Email: ueda@nagasaki-u.ac.jp or frs2016nagasaki@gmail.com
Registration: http://www.mdp.nagasaki-u.ac.jp/pain/frs2016_hp/index.html?
Fee: 20,000 Yen (approximately $175 USD)